Cargando…
Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges
Malignant bowel obstruction (MBO) is one of the most severe complications in patients with advanced ovarian cancer, with an estimated incidence up to 50%. Its presence is related to poor prognosis and a life expectancy measured in weeks for inoperable cases. Symptoms are usually difficult to manage...
Autores principales: | Gonzalez-Ochoa, Eduardo, Alqaisi, Husam A, Bhat, Gita, Jivraj, Nazlin, Lheureux, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805709/ https://www.ncbi.nlm.nih.gov/pubmed/36597479 http://dx.doi.org/10.2147/IJWH.S366680 |
Ejemplares similares
-
Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer
por: Lee, Yeh Chen, et al.
Publicado: (2019) -
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective
por: Lee, Yeh Chen, et al.
Publicado: (2018) -
Development of a Core Outcome Set for the research and assessment of inoperable malignant bowel obstruction
por: Bravington, Alison, et al.
Publicado: (2023) -
Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer
por: Peng, Xingang, et al.
Publicado: (2015) -
MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer
por: Madariaga, Ainhoa, et al.
Publicado: (2022)